Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge.
The aim of this study was to assess the diagnostic values of three breast tumor markers (i.e., CEA, CA153 and CA125) in milk and nipple discharge in the prediction of different breast diseases diagnoses.Three hundred thirty-six patients (96 breast cancer and 240 benign disease patients) with nipple...
Main Authors: | Song Zhao, Yu Mei, Jianli Wang, Kai Zhang, Rong Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4915693?pdf=render |
Similar Items
-
Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases
by: Anselmi Loretta, et al.
Published: (2006-11-01) -
Evaluating Lung Cancer with Tumor Markers: CEA, CA 19-9 and CA 125
by: Aydın Balcı, et al.
Published: (2021-05-01) -
Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei
by: Lei Liang, et al.
Published: (2021-10-01) -
Tumor biomarkers CEA, CA19.9, CA15.3 and AFP levels in the serum of patients with COVID-19
by: Abubaker H. Ali, et al.
Published: (2022-04-01) -
Primary Cutaneous Mucinous Carcinoma Monitoring: A Role for CA15.3 and CEA?
by: Antonin Ginguay, et al.
Published: (2022-12-01)